Encompass Health Corporation's stock surged 23.31% in after-hours trading on Thursday, following the release of the company's fourth-quarter financial results.
The significant price movement was driven by the company reporting better-than-expected earnings for Q4 2025. Encompass Health posted adjusted earnings per share of $1.46, surpassing the analyst consensus estimate of $1.30. Quarterly sales of $1.545 billion also exceeded expectations. Furthermore, the company issued its 2026 guidance, projecting adjusted earnings per share in the range of $5.81 to $6.10, signaling confidence in its future growth trajectory.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments